FDA Clearance Tracker · P140009-S047
Brio Neurostimulation System
Last checked: Nov 20, 2026Latest source record: Jul 15, 2019 (this decision)Source: openFDAMethods & limitations
Decided
Jul 15, 2019
Approved
Time to decision
69 days
Received May 7, 2019. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P140009-S047
- Device name
- Brio Neurostimulation System
- Applicant
- ABBOTT MEDICAL
- Applicant location
- Plano, TX
- Received
- May 7, 2019
- Decided
- Jul 15, 2019
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P140009
Device type
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
Approval for a manufacturing site located at Midwest Sterilization Corporation, 1204 Lenco Avenue, Jackson, Missouri, as an alternate ethylene oxide sterilization site for numerous neuromodulation products.
Source documents
Other decisions for ABBOTT MEDICAL
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P260019 · Decided Oct 27, 2026 · 180 days after receipt
Device type: Para-device leak occluder (SJT) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.